Post-COVID-19 Syndrome Clinical Trial
Official title:
Cognitive Strategy Training in Post-COVID-19 Syndrome: A Feasibility Trial
The first aim of this study is to determine the feasibility of delivering CO-OP remotely to individuals experiencing cognitive impairments that limit everyday activities in post-COVID-19 syndrome (PCS). The second aim of this study is to assess the effect of CO-OP on activity performance, subjective and objective cognition, and quality of life in a sample of individuals with PCS. The research team hypothesizes that effect size estimations will indicate that CO-OP will have a greater positive effect, compared to an inactive control group, on activity performance, subjective and objective cognition, and quality of life in a sample of individuals who self-report PCS and cognitive impairment.
Status | Recruiting |
Enrollment | 65 |
Est. completion date | December 2025 |
Est. primary completion date | December 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 60 Years |
Eligibility | Inclusion Criteria: - self-reported cognitive symptoms persisting for at least 6 weeks following COVID-19 infection (Cognitive Failures Questionnaire (CFQ) score >43) - self-identified activity performance goals per the Canadian Occupational Performance Measure (COPM) - documented prior diagnosis of COVID-19 - read, write, and speak English fluently - ability to provide valid informed electronic consent Exclusion Criteria: - diagnosis of severe neurological or psychiatric condition(s) - dementia symptoms as indicated by a score of <23 on the Montreal Cognitive Assessment (MoCA) - untreated sleep apnea (=5 on the STOPBANG) - prior cancer treatment - severe depressive symptoms (>21 on the Patient Health Questionnaire-9) |
Country | Name | City | State |
---|---|---|---|
United States | University of Missouri Department of Occupational Therapy | Columbia | Missouri |
Lead Sponsor | Collaborator |
---|---|
University of Missouri-Columbia | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
United States,
Cicerone KD, Dahlberg C, Malec JF, Langenbahn DM, Felicetti T, Kneipp S, Ellmo W, Kalmar K, Giacino JT, Harley JP, Laatsch L, Morse PA, Catanese J. Evidence-based cognitive rehabilitation: updated review of the literature from 1998 through 2002. Arch Phys Med Rehabil. 2005 Aug;86(8):1681-92. doi: 10.1016/j.apmr.2005.03.024. — View Citation
Dawson DR, Anderson ND, Burgess P, Cooper E, Krpan KM, Stuss DT. Further development of the Multiple Errands Test: standardized scoring, reliability, and ecological validity for the Baycrest version. Arch Phys Med Rehabil. 2009 Nov;90(11 Suppl):S41-51. doi: 10.1016/j.apmr.2009.07.012. — View Citation
Geusgens CA, van Heugten CM, Cooijmans JP, Jolles J, van den Heuvel WJ. Transfer effects of a cognitive strategy training for stroke patients with apraxia. J Clin Exp Neuropsychol. 2007 Nov;29(8):831-41. doi: 10.1080/13803390601125971. — View Citation
Haskins EC, Cicerone KD, Trexler LE. Cognitive rehabilitation manual: Translating evidence-based recommendations into practice. ACRM Publishing; 2012.
McEwen S, Polatajko H, Baum C, Rios J, Cirone D, Doherty M, Wolf T. Combined Cognitive-Strategy and Task-Specific Training Improve Transfer to Untrained Activities in Subacute Stroke: An Exploratory Randomized Controlled Trial. Neurorehabil Neural Repair. 2015 Jul;29(6):526-36. doi: 10.1177/1545968314558602. Epub 2014 Nov 21. — View Citation
Wolf TJ, Polatajko H, Baum C, Rios J, Cirone D, Doherty M, McEwen S. Combined Cognitive-Strategy and Task-Specific Training Affects Cognition and Upper-Extremity Function in Subacute Stroke: An Exploratory Randomized Controlled Trial. Am J Occup Ther. 2016 Mar-Apr;70(2):7002290010p1-7002290010p10. doi: 10.5014/ajot.2016.017293. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Feasibility measures | Recruitment rate, retention rate | After study completion, an average of 12 weeks | |
Primary | Telehealth Usability Questionnaire (TUQ) | Measure of telehealth usability from participant's perspective. Self-report Likert scale of 1 (disagree) to 7 (agree) | After study completion, an average of 12 weeks | |
Primary | Acceptability of Intervention Measure (AIM) | Measure of intervention acceptability. Self-report Likert scale of 1 (completely disagree) to 5 (completely agree) | After study completion, an average of 12 weeks | |
Primary | Intervention Appropriateness Measure (IAM) | Measure of intervention appropriateness. Self-report Likert scale of 1 (completely disagree) to 5 (completely agree) | After study completion, an average of 12 weeks | |
Primary | Feasibility of Intervention Measure (FIM) | Measure of intervention feasibility. Self-report Likert scale of 1 (completely disagree) to 5 (completely agree) | After study completion, an average of 12 weeks | |
Primary | Canadian Occupational Performance Measure (COPM) | Self-report measure of activity performance. Minimum = 1, Maximum = 10. Higher scores mean better performance. | Pre-intervention (week 0), week 2, week 4, week 6, week 8, and post-intervention (week 12) | |
Secondary | Delis-Kaplan Executive Function System (DKEFS)- Color-Word Interference | Objective measure of inhibition and cognitive flexibility. Consists of 4 conditions (color naming, word reading, inhibition, and inhibition/switching). Therapist records client-corrected errors, noncorrected errors, and total time required for each domain. Increased errors and time indicate potential challenges with inhibition and cognitive flexibility. | Pre-intervention (week 0) and post-intervention (week 12) | |
Secondary | Patient-Reported Outcomes Measurement Information System (PROMIS) Cognitive Function | Self-report measure of cognition. Maximum=5, minimum=1. Higher scores indicate fewer perceived cognitive deficits. | Pre-intervention (week 0) and post-intervention (week 12) | |
Secondary | World Health Organization Quality of Life Assessment Instrument (WHOQOL-100) | Self-report measure of quality of life. Maximum=5, minimum=1. Higher scores indicate greater perceived quality of life. | Pre-intervention (week 0) and post-intervention (week 12) | |
Secondary | Cambridge Neuropsychological Test Automated Battery (CANTAB) Rapid Visual Information Processing Subtest | Objective measure of sustained attention. Other outcomes include latency (speed of response), probability of false alarms, and sensitivity. | Pre-intervention (week 0) and post-intervention (week 12) | |
Secondary | CANTAB Spatial Working Memory Subtest | Objective measure of working memory and strategy. | Pre-intervention (week 0) and post-intervention (week 12) | |
Secondary | CANTAB Stockings of Cambridge Subtest | Objective measure of planning and executive function. Other outcomes include problem-solving ability and time required to complete task. | Pre-intervention (week 0) and post-intervention (week 12) | |
Secondary | CANTAB Delayed Matching to Sample Subtest | Objective measure of short-term visual recognition memory and attention. Other outcomes include latency (speed of response), the number of correct patterns selected and a statistical measure giving the probability of an error after a correct or incorrect response. | Pre-intervention (week 0) and post-intervention (week 12) | |
Secondary | CANTAB Paired Associates Learning Subtest | Objective measure of visual episodic memory. Other outcomes include the errors made by the participant, the number of trials required to locate the pattern(s) correctly, memory scores and stages completed. | Pre-intervention (week 0) and post-intervention (week 12) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06073002 -
Effects of a Home-Based Exercise Intervention in Subjects With Long COVID
|
N/A | |
Completed |
NCT05047952 -
Vortioxetine for Post-COVID-19 Condition
|
Phase 2 | |
Completed |
NCT05812209 -
Stellate Ganglion Block to Treat Long COVID 19 Case Series
|
||
Recruiting |
NCT06091384 -
Inspiratory Muscle Strength Training in Post-Covid Syndrome
|
N/A | |
Not yet recruiting |
NCT06267300 -
Treatment of Post-COVID-19 With Hyperbaric Oxygen Therapy: a Randomized, Controlled Trial
|
Phase 3 | |
Recruiting |
NCT05986422 -
Methylprednisolone in Patients With Cognitive Deficits in Post-COVID-19 Syndrome (PCS)
|
Phase 2 | |
Not yet recruiting |
NCT05534997 -
Rehabilitation Therapy for Post COVID 19 Chronic Fatigue Syndrome
|
N/A | |
Recruiting |
NCT05638633 -
Prednisolone and Vitamin B1/6/12 in Patients With Post-Covid-Syndrome
|
Phase 3 | |
Active, not recruiting |
NCT05630040 -
VNS for Long-COVID-19
|
N/A | |
Recruiting |
NCT05841498 -
Immunoadsorption Study Mainz in Adults With Post-COVID Syndrome
|
N/A | |
Enrolling by invitation |
NCT05981872 -
EFFECT OF COGNITIVE BEHAVIORAL THERAPY ON DEPRESSION AND QUALITY OF LIFE IN PATIENTS WITH POST COVID-19
|
N/A | |
Active, not recruiting |
NCT05543408 -
Long COVID-19 Syndrome in Primary Care: A Novel Protocol of Exercise Intervention "CON-VIDA Clinical Trial"
|
N/A | |
Recruiting |
NCT05817032 -
Effect of Telerehabilitation Practice in Long COVID-19 Patients
|
N/A | |
Recruiting |
NCT05823896 -
imPROving Quality of LIFe In the Long COVID Patient
|
Phase 2 | |
Completed |
NCT05764070 -
Impact of Vagus Nerve Stimulation on Post-Aerobic Activity Recovery in Post SARS-CoV-2 Patients
|
N/A | |
Completed |
NCT05765591 -
Balneotherapy for Patients With Post-acute Coronavirus Disease (COVID) Syndrome
|
N/A | |
Recruiting |
NCT05918965 -
Vagus Stimulation in Female Long COVID Patients.
|
N/A | |
Not yet recruiting |
NCT06231238 -
Balance Acceptance and Commitment Therapy for Long COVID
|
Phase 2 | |
Completed |
NCT06282627 -
The COVID HOME Study: Prospective Cohort Study of Non-hospitalised COVID-19 Patients
|
||
Completed |
NCT05648734 -
Anti-Inflammatory and Anti-Fibrotic Drugs in Post COVID-19 Pulmonary Fibrosis
|